July 2024 update

CBD products cannot arrive by overseas mail

People cannot import any CBD products into New Zealand for personal use through overseas courier or mail services.

Misuse of Drugs (Medicinal Cannabis) Amendment Regulations 2024 · Starts 5 Jul 2024

What's changing

Medicinal cannabis definitions

The definition of cannabis-based ingredient would include dried cannabis intended for a dosage product. Starting material would also include initial cannabis extracts intended for further processing or extraction.

Minimum quality standard

The minimum quality standard would apply to medicinal cannabis intended for therapeutic use and cannabis-derived cannabidiol products intended for human therapeutic use, with exemptions including certain research uses and compliant exports.

Export permissions

Licensed cultivation and supply businesses would be able to export specified starting material, ingredients, products, seeds, and propagation material for testing, research, analysis, or further manufacturing, subject to the stated licence conditions.

Dosage product assessment fee

The fee for assessing a dosage product would be $6,700 excluding goods and services tax.

Research and personal CBD imports

Controlled-drug possession licences could cover non-therapeutic research involving industrial hemp and medicinal cannabis materials. People would be prohibited from importing CBD products for personal use by overseas courier or mail.

Who's affected

Medicinal cannabis growers, manufacturers, exporters, researchers, licence holders, CBD importers, and businesses applying for dosage product assessments.

When

These regulations took effect on 5 July 2024.

What you might need to do

Background

The government says the changes would support innovation, improve quality and scheme operations, remove export barriers, and help researchers use cannabis materials.

Read the official text on legislation.govt.nz